MSB 7.69% $1.19 mesoblast limited

MSB to dispute FDA finding in Type A meeting, page-24

  1. 92 Posts.
    lightbulb Created with Sketch. 7
    My confusion about this meeting is that all of the evidence that MSB have, has already been presented, voted on with an overwhelming majority by ODAC and still knocked back. What more can they present or do to overturn it?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.